Post-market Clinical Study to Confirm Safety and Performance of PuraStat® for the Management of Bleeding in Vascular Surgery.
CompletedOBSERVATIONAL
Enrollment
65
Participants
Timeline
Start Date
June 14, 2017
Primary Completion Date
July 5, 2019
Study Completion Date
August 30, 2019
Conditions
Vascular Anastomosis Surgery
Interventions
DEVICE
PuraStat®
Synthetic haemostatic material
Trial Locations (1)
Unknown
St George'S University Hospitals Nhs Foundation Trust, London
All Listed Sponsors
lead
3-D Matrix Europe SAS
INDUSTRY
NCT03103282 - Post-market Clinical Study to Confirm Safety and Performance of PuraStat® for the Management of Bleeding in Vascular Surgery. | Biotech Hunter | Biotech Hunter